Skip to main content
Premium Trial:

Request an Annual Quote

Astellas Pharma Renews License to GVK Biosciences Drug Databases

Premium

GVK Biosciences said this week that Japanese pharmaceutical company Astellas has renewed its license to the GVK Bio Structure Activity Relationship database, known as GOSTAR.

GOSTAR provides SAR, ADME, toxicity, preclinical, clinical, and structure information on compounds in the discovery and development stages as well as drugs that are currently on in the market.

The database currently includes information on more than 5.1 million compounds and 16.7 million SAR points.

GVK Bio is part of the GVK group, which provides contract research services in multiple industries, including infrastructure, manufacturing, life sciences, and the financial markets.

GVK Bio provides discovery services in chemistry, biology, and informatics; and development services for clinical research, clinical pharmacology, and process research and development to pharma and biotechnology companies.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.